HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virginia García-Cañas Selected Research

Colonic Neoplasms (Colon Cancer)

1/2017Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.
12/2016Comparative Study of Green Sub- and Supercritical Processes to Obtain Carnosic Acid and Carnosol-Enriched Rosemary Extracts with in Vitro Anti-Proliferative Activity on Colon Cancer Cells.
1/2016Capillary Electrophoresis in Food and Foodomics.
1/2016Comprehensive Proteomic Study of the Antiproliferative Activity of a Polyphenol-Enriched Rosemary Extract on Colon Cancer Cells Using Nanoliquid Chromatography-Orbitrap MS/MS.
6/2015Metabolomics of adherent mammalian cells by capillary electrophoresis-mass spectrometry: HT-29 cells as case study.
10/2014Comprehensive foodomics study on the mechanisms operating at various molecular levels in cancer cells in response to individual rosemary polyphenols.
1/2013Effect of rosemary polyphenols on human colon cancer cells: transcriptomic profiling and functional enrichment analysis.
8/2012CE/LC-MS multiplatform for broad metabolomic analysis of dietary polyphenols effect on colon cancer cells proliferation.
7/2012Global Foodomics strategy to investigate the health benefits of dietary constituents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Virginia García-Cañas Research Topics

Disease

9Colonic Neoplasms (Colon Cancer)
01/2017 - 07/2012
6Neoplasms (Cancer)
02/2019 - 08/2012
2Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 05/2017
1Cardiovascular Diseases (Cardiovascular Disease)
05/2022
1Colitis
01/2020
1Leukemia
08/2012
1Human Influenza (Influenza)
04/2007

Drug/Important Bio-Agent (IBA)

7PolyphenolsIBA
05/2017 - 07/2012
5salvinIBA
12/2018 - 10/2014
5Proteins (Proteins, Gene)FDA Link
05/2017 - 04/2007
4carnosolIBA
12/2018 - 10/2014
3IsotopesIBA
05/2017 - 01/2016
2DiterpenesIBA
12/2018 - 01/2016
2PolyaminesIBA
06/2015 - 08/2012
1resazurinIBA
05/2022
1trimethylamineIBA
05/2022
1Carnitine (L-Carnitine)FDA LinkGeneric
05/2022
1PhytochemicalsIBA
05/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2020
1Type I Tumor Necrosis Factor ReceptorsIBA
01/2020
1nobiletinIBA
02/2019
1Fluorouracil (Carac)FDA LinkGeneric
02/2019
1scutellareinIBA
02/2019
1sinensetinIBA
02/2019
1tangeretinIBA
02/2019
1Biomarkers (Surrogate Marker)IBA
02/2019
1FlavonesIBA
02/2019
1rosmanolIBA
12/2018
1Syntex adjuvant formulationIBA
12/2016
1Eflornithine (Ornidyl)FDA Link
06/2015
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
06/2015
1EnzymesIBA
10/2014
1Terpenes (Terpenoids)IBA
10/2014
1AntioxidantsIBA
08/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1NucleoproteinsIBA
04/2007
1Hemagglutinins (Hemagglutinin)IBA
04/2007
1AntigensIBA
04/2007